Found 4 matching trials
NK Cells Plus ICI for SCLC Maintenance PHASE2 This research study is designed for patients with extensive-stage small cel...
Show More Location
Tianjin First Central Hospital
Learn More & Join Trial
EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases PHASE1 In this multi-center open-label, non-randomized phase I/II intervention stu...
Show More Location
University Hospital Basel, Klinik für Infektiologie und Spitalhygiene
Learn More & Join Trial
Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant PHASE2 This is a Phase II pilot study to determine the efficacy of three fixed dos...
Show More Status
Enrolling By Invitation
Location
Phoenix Children's Hospital
Learn More & Join Trial
Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation PHASE2 This pilot clinical trial aims to evaluate the feasibility, adverse reactio...
Show More Location
Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology
Learn More & Join Trial